We endeavor to make new discoveries leading to the development of vaccines that are:
Easy to administer in resource-limited settings.
Easily produced by manufacturers in developing countries.
Protective against diseases of global public health importance.
At our labs in Seoul, we have microbiological, immunological, genomic containment, as well as animal facilities and teams with expertise in molecular biology, microbial genetics, bioinformatics, and immunology. We discover new vaccines, improve existing vaccines, and evaluate non-clinical performance and safety in promising vaccine candidates to reduce risk in clinical development.